Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Himalayas: Roxadustat in incident dialysis anemia
NCT02052310Phase 3Completed
- Sponsor
- FibroGen
- Start
- Feb 2014
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by FibroGen. Started Feb 2014; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02052310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052310.